-
EP2748356
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2748356
| EP2748356 - RENAL CELL CARCINOMA BIOMARKERS AND USES THEREOF [Right-click to bookmark this link] | Status | The application has been withdrawn Status updated on 13.03.2015 Database last updated on 31.08.2024 | Most recent event Tooltip | 13.03.2015 | Withdrawal of application | published on 15.04.2015 [2015/16] | Applicant(s) | For all designated states Somalogic, Inc. 2945 Wilderness Place Boulder, CO 80301 / US | [2014/27] | Inventor(s) | 01 /
OSTROFF, Rachel M. 10203 King Court Westminster Colorado 80031 / US | 02 /
WILLIAMS, Stephen Alaric 1188 Forest Avenue Boulder Colorado 80304 / US | 03 /
RIEL-MEHAN, Michael 845 W. Linden St. Louisville Colorado 80027 / US | 04 /
BRODY, Edward N. 4121 S. Hampton Circle Boulder Colorado 80301 / US | 05 /
STEWART, Alex A.E. 20 Wyola Prospect Waltham Massachusetts 02451 / US | 06 /
KATO, Shintaro 4840 Meredith Way Unit 10-203 Boulder Colorado 80303 / US | [2014/27] | Representative(s) | Clegg, Richard Ian Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
| Former [2014/27] | Clegg, Richard Ian Mewburn Ellis LLP 33 Gutter Lane London EC2V 8AS / GB | Application number, filing date | 12824991.9 | 22.08.2012 | WO2012US51944 | Priority number, date | US201161526133P | 22.08.2011 Original published format: US 201161526133 P | [2014/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2013028807 | Date: | 28.02.2013 | Language: | EN | [2013/09] | Type: | A2 Application without search report | No.: | EP2748356 | Date: | 02.07.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.02.2013 takes the place of the publication of the European patent application. | [2014/27] | Search report(s) | International search report - published on: | US | 15.05.2014 | Classification | IPC: | C40B30/04, C40B40/06, C40B40/10, G01N33/574, C12Q1/68, G06F19/00 | [2014/27] | CPC: |
G01N33/57438 (EP,US);
C12Q1/6886 (EP,US);
G16B25/00 (EP,US);
G16B25/10 (EP,US);
G16B25/30 (EP,US);
C12Q2600/118 (EP,US);
C12Q2600/158 (EP,US);
G01N2333/4703 (US);
G01N2333/4706 (US);
G01N2333/521 (US);
G01N2333/70503 (US);
G01N2333/78 (US);
G01N2333/805 (US);
G01N2333/8121 (US);
G01N2333/96433 (US);
G01N2333/96494 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/27] | Extension states | BA | 18.03.2014 | ME | 18.03.2014 | Title | German: | NIERENZELLKARZINOM-BIOMARKER UND VERWENDUNGEN DAVON | [2014/27] | English: | RENAL CELL CARCINOMA BIOMARKERS AND USES THEREOF | [2014/27] | French: | BIOMARQUEURS DU CARCINOME CELLULAIRE RÉNAL ET LEURS UTILISATIONS | [2014/27] | Entry into regional phase | 18.03.2014 | National basic fee paid | 18.03.2014 | Search fee paid | 18.03.2014 | Designation fee(s) paid | 18.03.2014 | Examination fee paid | Examination procedure | 18.03.2014 | Amendment by applicant (claims and/or description) | 18.03.2014 | Examination requested [2014/27] | 05.03.2015 | Application withdrawn by applicant [2015/16] | Fees paid | Renewal fee | 13.08.2014 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]US2005130193 (LUXON BRUCE A [US], et al); | [Y]WO2011050328 (UNIV CALIFORNIA [US], et al); | [Y]US2011171633 (COWENS WAYNE [US], et al) |